转移性前列腺癌患者-话题@MedSci - 梅斯（MedSci）

#转移性前列腺癌患者#

12篇内容 | 1131人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2240840, encodeId=9c1c22408404a, content=<a href='/topic/show?id=c8ee32526f3' target=_blank style='color:#2F92EE;'>#前列腺癌#</a> <a href='/topic/show?id=29a09340656' target=_blank style='color:#2F92EE;'>#转移性前列腺癌患者#</a>, objectTitle=European Radiology：定量MR指纹在前列腺癌患者转移性骨T1和T2测量中的重复性, objectType=article, longId=853846, objectId=92c0853846f7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240801/1722478199513_92910.jpg, objectUrl=/article/show_article.do?id=92c0853846f7, replyNumber=0, likeNumber=26, createdTime=2024-12-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=92c0853846f7, moduleTitle=European Radiology：定量MR指纹在前列腺癌患者转移性骨T1和T2测量中的重复性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=92c0853846f7)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1976585, encodeId=eb7219e65859d, content=<a href='/topic/show?id=29a09340656' target=_blank style='color:#2F92EE;'>#转移性前列腺癌患者#</a>, objectTitle=Eur Urol：非转移性前列腺癌患者中，高强度聚焦超声局部治疗后的癌症控制结果 , objectType=article, longId=299087, objectId=d12e29908ecd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d12e29908ecd, replyNumber=0, likeNumber=86, createdTime=2022-05-25, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d12e29908ecd, moduleTitle=Eur Urol：非转移性前列腺癌患者中，高强度聚焦超声局部治疗后的癌症控制结果 , moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d12e29908ecd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976584, encodeId=627119e6584ed, content=<a href='/topic/show?id=29a09340656' target=_blank style='color:#2F92EE;'>#转移性前列腺癌患者#</a>, objectTitle=Front Oncol：化疗对转移性前列腺癌患者的总生存期影响, objectType=article, longId=221253, objectId=76b2221253f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76b2221253f9, replyNumber=0, likeNumber=95, createdTime=2022-04-25, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76b2221253f9, moduleTitle=Front Oncol：化疗对转移性前列腺癌患者的总生存期影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=76b2221253f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976583, encodeId=9cbe19e6583a8, content=<a href='/topic/show?id=29a09340656' target=_blank style='color:#2F92EE;'>#转移性前列腺癌患者#</a>, objectTitle=JAMA Oncology：一种新可以更好地预测非转移性前列腺癌患者预后的新分期系统, objectType=article, longId=202517, objectId=e79120251eaf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e79120251eaf, replyNumber=0, likeNumber=72, createdTime=2020-12-30, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e79120251eaf, moduleTitle=JAMA Oncology：一种新可以更好地预测非转移性前列腺癌患者预后的新分期系统, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e79120251eaf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976582, encodeId=cc1219e65828b, content=<a href='/topic/show?id=29a09340656' target=_blank style='color:#2F92EE;'>#转移性前列腺癌患者#</a>, objectTitle=NEJM：Nubeqa（darolutamide）显著延长非转移性前列腺癌患者的寿命！, objectType=article, longId=200507, objectId=259720050e88, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=259720050e88, replyNumber=0, likeNumber=67, createdTime=2020-10-23, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=259720050e88, moduleTitle=NEJM：Nubeqa（darolutamide）显著延长非转移性前列腺癌患者的寿命！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=259720050e88)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976581, encodeId=858719e65817c, content=<a href='/topic/show?id=29a09340656' target=_blank style='color:#2F92EE;'>#转移性前列腺癌患者#</a>, objectTitle=2019ESMO-Asia：Darolutamide延缓非转移性前列腺癌患者的疾病进展和化疗时间, objectType=article, longId=183719, objectId=f1bc183e1902, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1bc183e1902, replyNumber=0, likeNumber=95, createdTime=2019-12-04, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1bc183e1902, moduleTitle=2019ESMO-Asia：Darolutamide延缓非转移性前列腺癌患者的疾病进展和化疗时间, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f1bc183e1902)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976580, encodeId=2a8419e6580f3, content=<a href='/topic/show?id=29a09340656' target=_blank style='color:#2F92EE;'>#转移性前列腺癌患者#</a>, objectTitle=Prostate Cancer P D：接受重症监护治疗的转移性前列腺癌患者接受姑息治疗的当前趋势和社会障碍研究, objectType=article, longId=183223, objectId=46cf183223b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46cf183223b5, replyNumber=0, likeNumber=182, createdTime=2019-11-28, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46cf183223b5, moduleTitle=Prostate Cancer P D：接受重症监护治疗的转移性前列腺癌患者接受姑息治疗的当前趋势和社会障碍研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=46cf183223b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976579, encodeId=08da19e65798c, content=<a href='/topic/show?id=29a09340656' target=_blank style='color:#2F92EE;'>#转移性前列腺癌患者#</a>, objectTitle=Lancet oncol：ADT疗法联合醋酸阿比特龙和强的松明显高危型转移性前列腺癌患者的总体存活期, objectType=article, longId=164282, objectId=b041164282af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b041164282af, replyNumber=0, likeNumber=92, createdTime=2019-12-22, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b041164282af, moduleTitle=Lancet oncol：ADT疗法联合醋酸阿比特龙和强的松明显高危型转移性前列腺癌患者的总体存活期, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b041164282af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976578, encodeId=ba9d19e65784a, content=<a href='/topic/show?id=29a09340656' target=_blank style='color:#2F92EE;'>#转移性前列腺癌患者#</a>, objectTitle=JCI:美国研究发现转移性前列腺癌患者细胞死亡与肿瘤细胞生长的相关性, objectType=article, longId=125544, objectId=519a125544bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=519a125544bb, replyNumber=0, likeNumber=90, createdTime=2018-08-11, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=519a125544bb, moduleTitle=JCI:美国研究发现转移性前列腺癌患者细胞死亡与肿瘤细胞生长的相关性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=519a125544bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976577, encodeId=e08219e6577fb, content=<a href='/topic/show?id=29a09340656' target=_blank style='color:#2F92EE;'>#转移性前列腺癌患者#</a>, objectTitle=2017 IOF立场声明：非转移性前列腺癌患者脆性骨折的预防, objectType=article, longId=110304, objectId=e39a110304e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e39a110304e3, replyNumber=0, likeNumber=67, createdTime=2018-07-03, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e39a110304e3, moduleTitle=2017 IOF立场声明：非转移性前列腺癌患者脆性骨折的预防, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e39a110304e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976576, encodeId=eea819e657607, content=<a href='/topic/show?id=29a09340656' target=_blank style='color:#2F92EE;'>#转移性前列腺癌患者#</a>, objectTitle=NEJM：应该对转移性前列腺癌患者进行基因检测？, objectType=article, longId=72328, objectId=95d0e2328ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95d0e2328ce, replyNumber=0, likeNumber=75, createdTime=2016-11-23, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95d0e2328ce, moduleTitle=NEJM：应该对转移性前列腺癌患者进行基因检测？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=95d0e2328ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976575, encodeId=ef7d19e65755d, content=<a href='/topic/show?id=29a09340656' target=_blank style='color:#2F92EE;'>#转移性前列腺癌患者#</a>, objectTitle=JAMA Oncol：放射治疗对新诊断非转移性前列腺癌患者有益（STAMPEDE试验）, objectType=article, longId=59664, objectId=71ef5966413, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71ef5966413, replyNumber=0, likeNumber=76, createdTime=2016-08-13, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71ef5966413, moduleTitle=JAMA Oncol：放射治疗对新诊断非转移性前列腺癌患者有益（STAMPEDE试验）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=71ef5966413)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1976574, encodeId=b07c19e65741a, content=<a href='/topic/show?id=29a09340656' target=_blank style='color:#2F92EE;'>#转移性前列腺癌患者#</a>, objectTitle=NEJM：多西他赛加ADT治疗显著延长转移性前列腺癌患者的总生存期, objectType=article, longId=54489, objectId=7cf754489be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cf754489be, replyNumber=0, likeNumber=101, createdTime=2016-04-19, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cf754489be, moduleTitle=NEJM：多西他赛加ADT治疗显著延长转移性前列腺癌患者的总生存期, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7cf754489be)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

转移性前列腺癌患者

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#前列腺癌# #转移性前列腺癌患者#

European Radiology：定量MR指纹在前列腺癌患者转移性骨T1和T2测量中的重复性

2024-12-04发表于陕西省

柳叶一刀 (审核中...)

前往app查看评论内容

#转移性前列腺癌患者#

Eur Urol：非转移性前列腺癌患者中，高强度聚焦超声局部治疗后的癌症控制结果

2022-05-25

柳叶一刀 (审核中...)

前往app查看评论内容

#转移性前列腺癌患者#

Front Oncol：化疗对转移性前列腺癌患者的总生存期影响

2022-04-25

柳叶一刀 (审核中...)

前往app查看评论内容

#转移性前列腺癌患者#

JAMA Oncology：一种新可以更好地预测非转移性前列腺癌患者预后的新分期系统

2020-12-30

柳叶一刀 (审核中...)

前往app查看评论内容

#转移性前列腺癌患者#

NEJM：Nubeqa（darolutamide）显著延长非转移性前列腺癌患者的寿命！

2020-10-23

柳叶一刀 (审核中...)

前往app查看评论内容

#转移性前列腺癌患者#

2019ESMO-Asia：Darolutamide延缓非转移性前列腺癌患者的疾病进展和化疗时间

2019-12-04

柳叶一刀 (审核中...)

前往app查看评论内容

#转移性前列腺癌患者#

Prostate Cancer P D：接受重症监护治疗的转移性前列腺癌患者接受姑息治疗的当前趋势和社会障碍研究

2019-11-28

柳叶一刀 (审核中...)

前往app查看评论内容

#转移性前列腺癌患者#

Lancet oncol：ADT疗法联合醋酸阿比特龙和强的松明显高危型转移性前列腺癌患者的总体存活期

2019-12-22

柳叶一刀 (审核中...)

前往app查看评论内容

#转移性前列腺癌患者#

JCI:美国研究发现转移性前列腺癌患者细胞死亡与肿瘤细胞生长的相关性

2018-08-11

柳叶一刀 (审核中...)

前往app查看评论内容

#转移性前列腺癌患者#

2017 IOF立场声明：非转移性前列腺癌患者脆性骨折的预防

2018-07-03

柳叶一刀 (审核中...)

前往app查看评论内容

#转移性前列腺癌患者#

NEJM：应该对转移性前列腺癌患者进行基因检测？

2016-11-23

柳叶一刀 (审核中...)

前往app查看评论内容

#转移性前列腺癌患者#

JAMA Oncol：放射治疗对新诊断非转移性前列腺癌患者有益（STAMPEDE试验）

2016-08-13

柳叶一刀 (审核中...)

前往app查看评论内容

#转移性前列腺癌患者#

NEJM：多西他赛加ADT治疗显著延长转移性前列腺癌患者的总生存期

2016-04-19

科室
- - 订阅+
  - 更多科室
工具
服务